Insider trade

CEO received an award of 7.1 PG derivative securities

Traded Aug 17, 2026 · Filed Aug 20, 2026

Procter & GamblePG

7.1
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 17, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 20, 2026

CEOGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000080424-26-000135
Filed / recorded

Aug 20, 2026, 11:52 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

PROCTER & GAMBLE Co

Issuer CIK

80424

Ticker

PG

Reporting person

Paul Gama

Relationship

Officer

Officer title

CEO- Health Care

Security

Restricted Stock Units

Table

Derivative (Table II)

Transaction date

Aug 17, 2026

Transaction code

A

Shares / units

7.0954

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

72.6299

Ownership form

Direct

Amendment

No

Footnotes from the filing

Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.